Capital Management Associates (New York)’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-6,000
Closed -$540K 103
2019
Q1
$540K Hold
6,000
0.84% 42
2018
Q4
$500K Hold
6,000
0.95% 42
2018
Q3
$647K Hold
6,000
0.8% 48
2018
Q2
$660K Hold
6,000
0.82% 47
2018
Q1
$602K Hold
6,000
0.93% 37
2017
Q4
$591K Hold
6,000
0.84% 52
2017
Q3
$562K Hold
6,000
0.8% 52
2017
Q2
$667K Hold
6,000
1.01% 29
2017
Q1
$589K Sell
6,000
-2,000
-25% -$191K 0.88% 45
2016
Q4
$735K Hold
8,000
1.15% 21
2016
Q3
$677K Hold
8,000
1.07% 30
2016
Q2
$651K Hold
8,000
1.11% 31
2016
Q1
$572K Hold
8,000
1.04% 37
2015
Q4
$569K Hold
8,000
0.83% 44
2015
Q3
$492K Hold
8,000
0.76% 51
2015
Q2
$580K Hold
8,000
0.77% 45
2015
Q1
$615K Hold
8,000
0.82% 44
2014
Q4
$536K Hold
8,000
0.78% 50
2014
Q3
$485K Hold
8,000
0.73% 53
2014
Q2
$470K Hold
8,000
0.69% 71
2014
Q1
$463K Hold
8,000
0.67% 73
2013
Q4
$428K Hold
8,000
0.63% 79
2013
Q3
$494K Hold
8,000
0.76% 61
2013
Q2
$485K Buy
+8,000
New +$477K 0.79% 53

Other funds holding DGX

Capital Management Associates (New York)'s DGX Position: Q2 2019 in Review

Capital Management Associates (New York) sold out of Quest Diagnostics (DGX) in Q2 2019, closing a stake of 6,000 shares — an estimated $540K sold.

Capital Management Associates (New York) first reported a position in DGX in Q2 2013 and held it in 24 quarters. The position peaked at $735K in Q4 2016. 654 funds tracked by Wall St. Rank hold DGX as of Q2 2019.

  • Capital Management Associates (New York) reported no remaining Quest Diagnostics position as of Q2 2019 after selling out during the quarter.
  • Capital Management Associates (New York) sold 6,000 Quest Diagnostics shares in Q2 2019, an estimated $540K.
  • Capital Management Associates (New York) first reported a position in Quest Diagnostics in Q2 2013 and held it in 24 quarters.
  • Capital Management Associates (New York)'s Quest Diagnostics position peaked at $735K in Q4 2016.
  • 654 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2019.

Based on Capital Management Associates (New York)'s 13F filing for Q2 2019, filed 8 Aug 2019.